Purchases and Sales Made in Q2 2022 in Alpine Immune Sciences, Inc. (ALPN)
This table provides information about the institutional ownership of Alpine Immune Sciences, Inc. (ALPN) during Q2 2022. The information is specifically focused on institutions that hold shares of ALPINE IMMUNE SCIENCES, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 14, 2024
Q2 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-155K- 78.32% |
$1.04M - $1.48M
|
42.9K
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Avidity Partners Management LP
Dallas, TX |
SELL
|
- |
-208K- 17.27% |
$1.4M - $1.98M
|
999K
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Bvf Inc
San Francisco, CA |
SELL
|
- |
-314K- 19.77% |
$2.11M - $2.99M
|
1.28M
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Tcg Crossover Management, LLC
Palo Alto, CA |
SELL
|
- |
-456K- 44.09% |
$3.06M - $4.34M
|
578K
$0
|
|
|
Aug 10, 2022
Q2 2022
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
SELL
|
- |
-1.2M- 28.67% |
$8.05M - $11.4M
|
2.99M
$0
|